These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 25322151)

  • 41. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Restoring regulation - IL-2 therapy in systemic lupus erythematosus.
    Humrich JY; Riemekasten G
    Expert Rev Clin Immunol; 2016 Nov; 12(11):1153-1160. PubMed ID: 27283871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
    Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
    Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis.
    Buitrago-Molina LE; Pietrek J; Noyan F; Schlue J; Manns MP; Wedemeyer H; Hardtke-Wolenski M; Jaeckel E
    J Autoimmun; 2021 Feb; 117():102591. PubMed ID: 33387980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance.
    Kong N; Lan Q; Chen M; Wang J; Shi W; Horwitz DA; Quesniaux V; Ryffel B; Liu Z; Brand D; Zou H; Zheng SG
    Arthritis Rheum; 2012 Aug; 64(8):2548-58. PubMed ID: 22605463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adoptive transfer of all-trans-retinal-induced regulatory T cells ameliorates experimental autoimmune arthritis in an interferon-gamma knockout model.
    Jeon EJ; Yoon BY; Lim JY; Oh HJ; Park HS; Park MJ; Lim MA; Park MK; Kim KW; Cho ML; Cho SG
    Autoimmunity; 2012 Sep; 45(6):460-9. PubMed ID: 22559266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.
    André S; Tough DF; Lacroix-Desmazes S; Kaveri SV; Bayry J
    Am J Pathol; 2009 May; 174(5):1575-87. PubMed ID: 19349365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.
    Schinnerling K; Aguillón JC; Catalán D; Soto L
    Clin Exp Immunol; 2017 Jul; 189(1):12-20. PubMed ID: 28369786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological effects of IL-21 on different immune cells and its role in autoimmune diseases.
    Gharibi T; Majidi J; Kazemi T; Dehghanzadeh R; Motallebnezhad M; Babaloo Z
    Immunobiology; 2016 Feb; 221(2):357-67. PubMed ID: 26466984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of the IL-33/ST2 axis in autoimmune disorders: Friend or foe?
    Liu X; Xiao Y; Pan Y; Li H; Zheng SG; Su W
    Cytokine Growth Factor Rev; 2019 Dec; 50():60-74. PubMed ID: 31085085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-2 and autoimmune disease occurrence and therapy.
    Geng X; Zhang R; Yang G; Jiang W; Xu C
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1462-7. PubMed ID: 23111957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-35 in immune-related diseases: protection or destruction.
    Zhang J; Zhang Y; Wang Q; Li C; Deng H; Si C; Xiong H
    Immunology; 2019 May; 157(1):13-20. PubMed ID: 30681737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study.
    Rosenzwajg M; Salet R; Lorenzon R; Tchitchek N; Roux A; Bernard C; Carel JC; Storey C; Polak M; Beltrand J; Amouyal C; Hartemann A; Corbeau P; Vicaut E; Bibal C; Bougnères P; Tran TA; Klatzmann D
    Diabetologia; 2020 Sep; 63(9):1808-1821. PubMed ID: 32607749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression.
    Goodman WA; Young AB; McCormick TS; Cooper KD; Levine AD
    J Immunol; 2011 Mar; 186(6):3336-45. PubMed ID: 21307288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.
    Hu Y; Wang X; Yu S; Hou Y; Ma D; Hou M
    Expert Opin Ther Targets; 2015 Jun; 19(6):723-32. PubMed ID: 25976230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic potential of interleukin-2 in autoimmune diseases.
    Yuan Y; Kolios AGA; Liu Y; Zhang B; Li H; Tsokos GC; Zhang X
    Trends Mol Med; 2022 Jul; 28(7):596-612. PubMed ID: 35624009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2.
    Dwyer CJ; Ward NC; Pugliese A; Malek TR
    Curr Diab Rep; 2016 Jun; 16(6):46. PubMed ID: 27076179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
    Wu D; Wang J; Pae M; Meydani SN
    Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory T cells in immune-mediated renal disease.
    Ghali JR; Wang YM; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2016 Feb; 21(2):86-96. PubMed ID: 26206106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DAPT reverses the Th17/Treg imbalance in experimental autoimmune uveitis in vitro via inhibiting Notch signaling pathway.
    Yin X; Wei H; Wu S; Wang Z; Liu B; Guo L; Bi H; Guo D
    Int Immunopharmacol; 2020 Feb; 79():106107. PubMed ID: 31863921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.